| An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice (NCT00576368) | Sanofi | 2003-06-01 |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I) (NCT00249795) | Sanofi | 2003-06-01 |
| Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT) (NCT00067093) | Sanofi | 2003-05-01 |
| Leflunomide + Methotrexate in Rheumatoid Arthritis (NCT00563849) | Sanofi | 2003-05-01 |
| Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes (NCT00174681) | Sanofi | 2003-04-01 |
| Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma (NCT00631579) | Sanofi | 2003-04-01 |
| A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults (NCT00981175) | Sanofi | 2003-04-01 |
| Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine) (NCT00653302) | Sanofi | 2003-04-01 |
| EXIBIT: Oxaliplatin in Biliary Tract Cancer (NCT00174564) | Sanofi | 2003-04-01 |
| Insomnia and Daytime Function in Osteoarthritis (NCT00530556) | Sanofi | 2003-03-01 |
| TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian (NCT00539669) | Sanofi | 2003-03-01 |
| Levofloxacin, Chronic Bacterial Prostatitis (NCT00277511) | Sanofi | 2003-03-01 |
| Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome (NCT00563771) | Sanofi | 2003-03-01 |
| Glycemic Optimization Treatment Study (NCT00552370) | Sanofi | 2003-03-01 |
| Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit (NCT00637611) | Sanofi | 2003-02-01 |
| Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice (NCT00564187) | Sanofi | 2003-02-01 |
| The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score (NCT00540891) | Sanofi | 2003-02-01 |
| Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen (NCT00638118) | Sanofi | 2003-02-01 |
| POWER Point of Care Effect on Satisfaction of Treatment (NCT00549068) | Sanofi | 2003-02-01 |
| Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction (NCT00714961) | Sanofi | 2003-02-01 |
| Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine (NCT00636870) | Sanofi | 2003-02-01 |
| Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS) (NCT00357149) | Sanofi | 2003-01-01 |
| TELICAST : Telithromycin in Acute Exacerbations of Asthma (NCT00273520) | Sanofi | 2003-01-01 |
| Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer (NCT00782041) | Sanofi | 2003-01-01 |
| Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas (NCT00538018) | Sanofi | 2003-01-01 |
| Leflunomide in Systemic Lupus Erythematosus (NCT00637819) | Sanofi | 2003-01-01 |
| Docetaxel in Head and Neck Cancer (NCT00261703) | Sanofi | 2002-12-01 |
| Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function (NCT00648453) | Sanofi | 2002-12-01 |
| AMS VS MOXI Ketek vs Avelox in AMS (NCT00537563) | Sanofi | 2002-12-01 |
| Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine (NCT00637585) | Sanofi | 2002-12-01 |
| Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women (NCT00353080) | Sanofi | 2002-12-01 |
| Taxotere + Cisplatin in Nasopharyngeal Carcinoma (NCT00436293) | Sanofi | 2002-12-01 |
| Risedronate in Postmenopausal Women With Low Bone Density (NCT00351091) | Sanofi | 2002-11-01 |
| Extension to Study HMR1964A/3011 in Belgium (NCT00576862) | Sanofi | 2002-11-01 |
| A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer (NCT00611507) | Sanofi | 2002-11-01 |
| Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents (NCT00046501) | Sanofi | 2002-11-01 |
| TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN (NCT00539630) | Sanofi | 2002-11-01 |
| Insulin Glargine in Type 1 Diabetes Mellitus (NCT00272090) | Sanofi | 2002-11-01 |
| Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking Cessation (NCT00459173) | Sanofi | 2002-11-01 |
| Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD (NCT00538148) | Sanofi | 2002-11-01 |
| TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer (NCT00399750) | Sanofi | 2002-11-01 |
| PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+Lispro (NCT00540709) | Sanofi | 2002-11-01 |
| Comparison of Efficacy and Safety of Rimonabant 5mg/Day or 20mg/Day Versus Placebo in Smoking Cessation (NCT00464165) | Sanofi | 2002-11-01 |
| Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model. (NCT00547768) | Sanofi | 2002-11-01 |
| Oxaliplatin in Rectal Cancer (NCT00259363) | Sanofi | 2002-10-01 |
| 20 Week Bridging Study in Type II DM (NCT00563225) | Sanofi | 2002-10-01 |
| Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) (NCT00050817) | Sanofi | 2002-10-01 |
| Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25) (NCT00077792) | Sanofi | 2002-10-01 |
| Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer (NCT00094081) | Sanofi | 2002-10-01 |
| Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide (NCT00290953) | Sanofi | 2002-10-01 |
| Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride (NCT00633425) | Sanofi | 2002-10-01 |
| Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus (NCT00353691) | Sanofi | 2002-10-01 |
| Risedronate in the Prevention of Osteoporosis in Postmenopausal Women (NCT00402441) | Sanofi | 2002-09-01 |
| Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US) (NCT00358228) | Sanofi | 2002-09-01 |
| European Study of Dronedarone in Atrial Fibrillation (NCT00697086) | Sanofi | 2002-08-01 |
| NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT) (NCT00916097) | Sanofi | 2002-07-01 |
| Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy (NCT00616694) | Sanofi | 2002-07-01 |
| Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma (NCT00664144) | Sanofi | 2002-07-01 |
| XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy (NCT00272051) | Sanofi | 2002-07-01 |
| Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension (NCT00529750) | Sanofi | 2002-07-01 |
| Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer. (NCT00425191) | Sanofi | 2002-07-01 |
| Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease. (NCT00798005) | Sanofi | 2002-06-01 |
| Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE) (NCT00077818) | Sanofi | 2002-06-01 |
| Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer (NCT00263029) | Sanofi | 2002-06-01 |
| European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure (NCT00696631) | Sanofi | 2002-06-01 |
| 12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes. (NCT00046150) | Sanofi | 2002-05-01 |
| Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial) (NCT00390728) | Sanofi | 2002-04-01 |
| Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis (NCT00741897) | Sanofi | 2002-03-01 |
| Objective Study in Rheumatoid Arthritis (NCT00451971) | Sanofi | 2002-03-01 |
| A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus (NCT00399724) | Sanofi | 2002-03-01 |
| Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease (NCT00368797) | Sanofi | 2002-03-01 |
| Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma (NCT00044811) | Sanofi | 2002-03-01 |
| EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization (NCT00077753) | Sanofi | 2002-02-01 |
| Lantus in Prediabetes (NCT00348972) | Sanofi | 2002-02-01 |
| Long-Term Safety Performance of Fexofenadine in Asthma (NCT00045955) | Sanofi | 2002-02-01 |
| Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma (NCT00044824) | Sanofi | 2002-02-01 |
| Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer (NCT00452985) | Sanofi | 2002-02-01 |
| Gene Expression and Tolerability Study of NV1FGF in Patients With Peripheral Artery Occlusive Disease Planned to Undergo Major Amputation (NCT01157143) | Sanofi | 2002-01-01 |
| HUPS: Hyalgan Use in Painful Shoulder (NCT00377624) | Sanofi | 2002-01-01 |
| Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses (NCT00228163) | Sanofi | 2002-01-01 |
| Glulisine Pre- and Postmeal (NCT00290043) | Sanofi | 2001-12-01 |
| Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin (NCT00384215) | Sanofi | 2001-12-01 |
| Insulin Glargine Combination Therapies in Type II Diabetics (NCT00783744) | Sanofi | 2001-12-01 |
| Docetaxel in Breast Cancer (NCT00312208) | Sanofi | 2001-11-01 |
| EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS) (NCT00259428) | Sanofi | 2001-11-01 |
| American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm (NCT00259376) | Sanofi | 2001-11-01 |
| SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1 (NCT00313937) | Sanofi | 2001-11-01 |
| 32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellitus (NCT00537251) | Sanofi | 2001-11-01 |
| Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment (NCT00046462) | Sanofi | 2001-11-01 |
| A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy (NCT00069888) | Sanofi | 2001-11-01 |
| Obese Patients With Type 2 Diabetes (NCT00029848) | Sanofi | 2001-10-01 |
| Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe) (NCT00386061) | Sanofi | 2001-10-01 |
| Docetaxel in Non Small Cell Lung Cancer (NSCLC) (NCT00258739) | Sanofi | 2001-10-01 |
| Obese Patients With Untreated Dyslipidemias (NCT00029835) | Sanofi | 2001-09-01 |
| Obese Patients With or Without Comorbidities (RIO-North America) (NCT00029861) | Sanofi | 2001-08-01 |
| Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT). (NCT00032747) | Sanofi | 2001-08-01 |
| SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes (NCT00043784) | Sanofi | 2001-08-01 |
| Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer (NCT00521521) | Sanofi | 2001-07-01 |
| Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment (NCT01336751) | Sanofi | 2001-07-01 |
| Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer (NCT00403624) | Sanofi | 2001-07-01 |